Global Acetaminophen Injection Market Growth (Status and Outlook) 2024-2030
Acetaminophen injection is a sterile solution containing the active ingredient acetaminophen, also known as paracetamol. Acetaminophen is a widely used over-the-counter (OTC) medication known for its analgesic (pain-relieving) and antipyretic (fever-reducing) properties. While acetaminophen is commonly taken orally in tablet or liquid form, acetaminophen injection is administered intravenously for the management of moderate to severe pain or fever when oral administration is not feasible or appropriate. This report covers only acetaminophen injection for human use.
The global Acetaminophen Injection market size is projected to grow from US$ 749 million in 2024 to US$ 898 million in 2030; it is expected to grow at a CAGR of 3.1% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Acetaminophen Injection Industry Forecast” looks at past sales and reviews total world Acetaminophen Injection sales in 2022, providing a comprehensive analysis by region and market sector of projected Acetaminophen Injection sales for 2023 through 2029. With Acetaminophen Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Acetaminophen Injection industry.
This Insight Report provides a comprehensive analysis of the global Acetaminophen Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Acetaminophen Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Acetaminophen Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Acetaminophen Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Acetaminophen Injection.
Global key players of Acetaminophen Injection include Mallinckrodt, Sandoz, Pfizer, etc. The top three players hold a share over 67%. North America is the largest market, and has a share about 39%, followed by Europe and Asia-Pacific with share 30% and 16%, separately. In terms of product type, 10 mg/mL is the largest segment, occupied for a share of 68%. In terms of application, Hospital has a share about 79 percent.
This report presents a comprehensive overview, market shares, and growth opportunities of Acetaminophen Injection market by product type, application, key players and key regions and countries.
Segmentation by Type:
10 mg/mL
100 mg/mL
150 mg/mL
Segmentation by Application:
Hospital
Clinic
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
10 mg/mL
100 mg/mL
150 mg/mL
Segmentation by Application:
Hospital
Clinic
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Mallinckrodt
Sandoz
Pfizer
Fresenius Kabi
Terumo
B. Braun Medical
Eugia
Accord Healthcare
Hikma
Please note: The report will take approximately 2 business days to prepare and deliver.